Opus Genetics
IRD
35 hedge funds and large institutions have $10.1M invested in Opus Genetics in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
41% more capital invested
Capital invested by funds: $7.15M → $10.1M (+$2.91M)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
3% less funds holding
Funds holding: 36 → 35 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$196K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$38.4K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$35.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.21M |
| 2 |
Millennium Management
New York
|
-$8K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$6.45K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$5K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$2.24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$561 | +4 | +57% |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | -$2.24K | -16 | -73% |
|
28
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
AT
29
Arden Trust
Wilmington,
Delaware
| $13 | – | – | – |
|
|
FHC
30
First Heartland Consultants
Lake St. Louis,
Missouri
| $5 | – | – | – |
|
|
31
Millennium Management
New York
| – | -$8K | -53 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$6.45K | -46 | -96% |
|
|
TSS
33
Two Sigma Securities
New York
| – | -$5K | -31 | Closed |
|
IRD Hedge Fund Activity: Q2 2016 in Review
35 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2016, worth a combined $10.1M — up 41% from $7.15M a quarter earlier.
Fund positioning in IRD was balanced in Q2 2016: 2 funds opened new positions, 2 closed out, 9 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $196K. The largest seller was Sabby Management, cutting an estimated $1.21M.
- 35 institutional investors held Opus Genetics (IRD) as of Q2 2016, down from 36 in Q1 2016.
- Funds reported $10.1M of Opus Genetics stock for Q2 2016, up 41% quarter-over-quarter.
- 2 funds opened new Opus Genetics positions in Q2 2016 and 2 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q2 2016 was Renaissance Technologies, an estimated $196K added.
- The largest Opus Genetics seller in Q2 2016 was Sabby Management, an estimated $1.21M sold.
Based on aggregated 13F filings for Q2 2016.